Publications by authors named "P Cottu"

Claim this Profile
A
Association Between Daily Timing of Everolimus and Survival in High-Risk HR+/HER2- Early Breast Cancer: A Sub-Analysis of the UCBG-UNIRAD Trial.
Enora Laas, Anne-Sophie Hamy, Thomas Bachelot, Paul Gougis, Jérôme Lemonnier, Paul Cottu

Clin Pharmacol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and toxicity of post-neoadjuvant trastuzumab emtansine in HER2-positive breast cancer patients treated at Institut Curie Hospitals.
Alexandre De Moura, Orane Gleizes, Luc Cabel, Anne Bethune-Volters, Audrey Bellesoeur, Paul Cottu

Sci Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Extracellular Matrix-Producing Subset of Cancer-Associated Fibroblasts Drives Chemoresistance in Breast Cancer via SRC Activation and G0S2 Upregulation.
Isabella Hofer, Yann Kieffer, Arianna Mencattini, Hugo Croizer, Rana Mhaidly, Paul H Cottu

Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finding the right tool for the specific task: navigating RWE tools and checklists.
Richard Willke, Paul Cottu, Andrew Briggs, Uwe Siebert, Connie Chen

Future Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended follow-up of palbociclib with fulvestrant or letrozole for endocrine-sensitive, hormone receptor-positive/HER2-negative advanced breast cancer in the PARSIFAL trial.
A Llombart-Cussac, J M Pérez-García, M Bellet, F Dalenc, M Gil-Gil, P Cottu

ESMO Open· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis